Airidas Rimkunas
Overview
Explore the profile of Airidas Rimkunas including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
20
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Januskevicius A, Vasyle E, Rimkunas A, Palacionyte J, Kalinauskaite-Zukauske V, Malakauskas K
Biomolecules
. 2025 Jan;
14(12.
PMID: 39766355
Eosinophils are central inflammatory cells in asthma; however, a portion of patients with chronic obstructive pulmonary disease (COPD) have blood or sputum eosinophilia, a condition termed eosinophilic COPD (eCOPD), which...
2.
Januskevicius A, Vasyle E, Rimkunas A, Malakauskas K
Diagnostics (Basel)
. 2024 Nov;
14(21).
PMID: 39518415
Asthma is a chronic inflammatory process that leads to airway narrowing, causing breath loss followed by spasms, wheezing, and shortness of breath. Within the asthmatic lungs, interaction among various immune...
3.
Palacionyte J, Januskevicius A, Vasyle E, Rimkunas A, Miliauskas S, Malakauskas K
Diagnostics (Basel)
. 2024 Jul;
14(13).
PMID: 39001236
Anti-interleukin (IL) 5 is an effective treatment modality for inhibiting eosinophilic inflammation in patients with T2-high severe asthma. The aim of this study was to determine the clinical efficacy and...
4.
Dimiene I, Hoppenot D, Vajauskas D, Padervinskiene L, Rimkunas A, Zemaitis M, et al.
J Clin Med
. 2024 May;
13(10).
PMID: 38792478
: Chronic obstructive pulmonary disease (COPD) has significant systemic manifestations, including cardiovascular morbidity. The main aim of our study was to evaluate the effect of short-term COPD treatment with tiotropium/olodaterol...
5.
Palacionyte J, Januskevicius A, Vasyle E, Rimkunas A, Bajoriuniene I, Vitkauskiene A, et al.
Biomedicines
. 2024 Jan;
12(1).
PMID: 38275403
In distinguishing the allergic asthma (AA) phenotype, it has been identified that specific biomarkers could assist; however, none of them are considered ideal. This study aimed to analyze three groups...
6.
Rimkunas A, Januskevicius A, Vasyle E, Palacionyte J, Janulaityte I, Miliauskas S, et al.
Int J Mol Sci
. 2023 Feb;
24(4).
PMID: 36834879
Airway remodeling is a hallmark feature of asthma, and one of its key structural changes is increased airway smooth muscle (ASM) mass and disturbed extracellular matrix (ECM) homeostasis. Eosinophil functions...
7.
Palacionyte J, Januskevicius A, Vasyle E, Rimkunas A, Bajoriuniene I, Miliauskas S, et al.
Cells
. 2022 Dec;
11(23).
PMID: 36497064
Blood eosinophils can be described as inflammatory-like (iEOS-like) and lung-resident-like (rEOS-like) eosinophils. This study is based on the hypothesis that eosinophilopoetins such as interleukin (IL)-3 and IL-5 and granulocyte-macrophage colony-stimulating...
8.
Janulaityte I, Januskevicius A, Rimkunas A, Palacionyte J, Vitkauskiene A, Malakauskas K
Int J Mol Sci
. 2022 Apr;
23(8).
PMID: 35456903
The impaired production of extracellular matrix (ECM) proteins by airway smooth muscle cells (ASMC) and pulmonary fibroblasts (PF) is a part of airway remodeling in asthma. This process might be...
9.
Jurkeviciute E, Januskevicius A, Rimkunas A, Palacionyte J, Malakauskas K
J Pers Med
. 2021 Sep;
11(9).
PMID: 34575607
Eosinophilic inflammation is one of the main pathophysiological features in asthma. Two subtypes of eosinophils exist in the lung and systemic circulation: lung-resident eosinophils (rEOS) and inflammatory eosinophils (iEOS). We...